CGN
中广核
elsewhere's corpus does not cover CGN as a subject. The bundle contains no entity card description, relations, or document chunks actually about CGN — only a company name in the search results with no accompanying facts. The retrieved materials instead cover unrelated topics: ZhenFund portfolio news (Weijing Energy Storage, Hanwei Technology, Jingtai Technology), Source Code Capital deals (Silicon Based Bionics, METiS Pharmaceuticals), and background mentions of other entities. No information is available to state what CGN is, when it was founded, what it does, or who runs it.
AI-generated — may contain errors, please verify.
Coverage
Linear Capital Leads Angel Round Investment in Yuansuan Technology, Which Completes Hundreds of Millions of Yuan in Series C1 Funding
Recently, Yuansuan Technology, a Linear Capital angel-round lead investment, completed a Series C1 raise of several hundred million RMB. This round was jointly invested by CITIC Securities, Zhejiang Financial Holdings, and others, with existing shareholders including CDH Venture Capital continuing to increase their stakes.
Trekking to Riyadh
Opportunity, wealth, and a surging tide of people.
Everything Has Two Sides: How Can "Nuclear Radiation" Be Used to Make Anti-Cancer Drugs? | FreeS Report 28
Now is the spring of radiopharmaceuticals.
Code View | Source Code Capital's Wu Fan: Opportunities and Advantages — China's New Energy in a New Cycle
